DGCI to Review Applications For Full Market Approval of Covaxin And Covishield Vaccine Today
Bharat Biotech had on Thursday announced that its 'Covaxin' was now a universal vaccine approved for both adults and children.
New Delhi, January 14: The Drugs Controller General of India (DCGI) headed Subject Expert Committee will on Friday review applications of SII and Bharat Biotech for Covishield and Covaxin vaccines for full market approval to the vaccines, said reports. Bharat Biotech had on Thursday announced that its 'Covaxin' was now a universal vaccine approved for both adults and children.
DCGI's Subject Expert Committee to review applications of Bharat Biotech and SII for full market approval to Covaxin and Covishield today: Sources
— ANI (@ANI) January 14, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jan 14, 2022 10:04 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
